Prostaglandin-endoperoxide synthase 2 (PTGS2) might mediate the CXCR2 signaling to inversely control the breast cancer metastasis and chemoresistance through the regulation of EMT, apoptosis, and senescence (Xu et al., 2018). Here, PTGS2 is linked to breast cancer.